Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Internalization | 11 | 2025 | 87 | 2.410 |
Why?
|
| Ebolavirus | 5 | 2025 | 38 | 2.140 |
Why?
|
| Viral Envelope Proteins | 6 | 2025 | 102 | 2.100 |
Why?
|
| HIV-1 | 10 | 2020 | 716 | 1.550 |
Why?
|
| Hemorrhagic Fever, Ebola | 3 | 2025 | 28 | 1.200 |
Why?
|
| HIV Infections | 8 | 2020 | 962 | 1.070 |
Why?
|
| Antibodies, Neutralizing | 3 | 2020 | 207 | 1.060 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2015 | 28 | 0.870 |
Why?
|
| Protein Conformation | 4 | 2025 | 774 | 0.800 |
Why?
|
| Membrane Fusion | 5 | 2025 | 67 | 0.720 |
Why?
|
| Antibodies, Viral | 2 | 2020 | 319 | 0.700 |
Why?
|
| Dengue | 1 | 2019 | 96 | 0.630 |
Why?
|
| Dengue Virus | 1 | 2019 | 99 | 0.620 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 569 | 0.530 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 641 | 0.520 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2020 | 133 | 0.510 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 761 | 0.500 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2025 | 78 | 0.480 |
Why?
|
| Protein Binding | 5 | 2024 | 1601 | 0.470 |
Why?
|
| Flow Cytometry | 1 | 2016 | 669 | 0.440 |
Why?
|
| Immune Evasion | 1 | 2012 | 69 | 0.370 |
Why?
|
| HIV Antibodies | 1 | 2012 | 144 | 0.360 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1005 | 0.350 |
Why?
|
| Purinergic P2X Receptor Antagonists | 2 | 2020 | 7 | 0.320 |
Why?
|
| Mutation | 4 | 2025 | 2573 | 0.290 |
Why?
|
| Virus Attachment | 3 | 2024 | 18 | 0.240 |
Why?
|
| Jurkat Cells | 2 | 2016 | 110 | 0.240 |
Why?
|
| HIV Fusion Inhibitors | 2 | 2016 | 9 | 0.240 |
Why?
|
| HEK293 Cells | 4 | 2020 | 618 | 0.230 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 121 | 0.220 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2024 | 54 | 0.220 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 112 | 0.210 |
Why?
|
| Humans | 18 | 2025 | 62681 | 0.210 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 54 | 0.160 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 196 | 0.160 |
Why?
|
| Palatine Tonsil | 1 | 2018 | 10 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2018 | 159 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 263 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2024 | 455 | 0.130 |
Why?
|
| Viremia | 1 | 2017 | 44 | 0.130 |
Why?
|
| Receptors, IgG | 1 | 2017 | 37 | 0.130 |
Why?
|
| Cell Line | 4 | 2016 | 2038 | 0.130 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 38 | 0.130 |
Why?
|
| Virology | 1 | 2016 | 15 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 189 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 97 | 0.120 |
Why?
|
| Cell Communication | 1 | 2016 | 131 | 0.120 |
Why?
|
| HIV Protease | 1 | 2016 | 120 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 151 | 0.120 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 463 | 0.120 |
Why?
|
| Point Mutation | 1 | 2015 | 165 | 0.120 |
Why?
|
| Receptors, Purinergic P2X | 1 | 2014 | 1 | 0.110 |
Why?
|
| Purinergic Antagonists | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 182 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 239 | 0.110 |
Why?
|
| Virion | 1 | 2014 | 121 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 670 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 2013 | 56 | 0.100 |
Why?
|
| Allosteric Regulation | 2 | 2024 | 69 | 0.100 |
Why?
|
| Protein Domains | 2 | 2024 | 148 | 0.090 |
Why?
|
| CD4 Antigens | 1 | 2012 | 149 | 0.090 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 12 | 0.090 |
Why?
|
| Epitopes | 1 | 2012 | 295 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2013 | 389 | 0.090 |
Why?
|
| Virus Replication | 3 | 2016 | 318 | 0.080 |
Why?
|
| Calcium | 2 | 2023 | 571 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2024 | 493 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 866 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2017 | 95 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2011 | 794 | 0.060 |
Why?
|
| Single Molecule Imaging | 1 | 2024 | 21 | 0.060 |
Why?
|
| Endosomes | 1 | 2023 | 178 | 0.050 |
Why?
|
| Binding Sites | 1 | 2024 | 900 | 0.050 |
Why?
|
| Animals | 2 | 2016 | 20581 | 0.040 |
Why?
|
| Zidovudine | 1 | 2018 | 12 | 0.040 |
Why?
|
| Benzenesulfonates | 1 | 2018 | 13 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2018 | 22 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 36 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2020 | 142 | 0.040 |
Why?
|
| Virulence | 1 | 2018 | 195 | 0.040 |
Why?
|
| Pyridines | 1 | 2018 | 111 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 336 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 318 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2017 | 24 | 0.030 |
Why?
|
| Reproductive Tract Infections | 1 | 2016 | 1 | 0.030 |
Why?
|
| Virus Release | 1 | 2016 | 14 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 105 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2014 | 37 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 933 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 36 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2014 | 59 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2013 | 47 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 369 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 1180 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2013 | 272 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1611 | 0.020 |
Why?
|
| Birds | 1 | 2011 | 9 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 261 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2011 | 73 | 0.020 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2011 | 41 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 105 | 0.020 |
Why?
|
| Female | 3 | 2017 | 32491 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 245 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 1508 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3022 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2154 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 17364 | 0.010 |
Why?
|
| Male | 1 | 2017 | 29486 | 0.010 |
Why?
|